Regulation of Aseptic Processing in the 21st Century - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulation of Aseptic Processing in the 21st Century
The authors question certain aspects of the industry's current regulatory-compliance strategy and suggest that aseptic-process control and evaluation should be revised.


Pharmaceutical Technology
Volume 35, pp. s46-s50

References

1. FDA, Sterile Drug Products Produced by Aseptic Processing (Rockville, MD, Jun. 1987).

2. FDA, Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practices (Rockville, MD, Sep. 2004).

3. EMA, Annex 1, Sterile Medicinal Products (London, 2009).

4. Task Force on Sterile Drug Products Produced by Aseptic Processing, (with support from the Japanese Ministry of Health, Labor, and Welfare), Guidance for Industry—Sterile Drug Products Produced by Aseptic Processing, (Tokyo, 2005).

5. J. Agalloco and J. Akers, Pharm. Technol. 30 (7), 60–76 (2006).

6. M. Miller and M. Walsh, PDA Annual Meeting (Las Vegas, 2009).

7. International Standards Organization, Standards 14644-1 to 8: Clean Rooms and Associated Controlled Environments (Geneva, 1999).

8. B. Reinmuller, Building Services Engineering, Bulletin 56, (Royal Institute of Technology, Stockholm, 2001).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here